Aridis Pharmaceuticals (ARDS) BidaskScore is lowered to Strongly Sold

Aridis Pharmaceuticals, Inc.

The BidaskScore of Aridis Pharmaceuticals Inc. ARDSARDS shows that the shares of the company are now ARDSStrongly Bought Strongly Sold by investors.

The BidaskScore of the PharmaceuticalsPharmaceuticals shows that the sector is PharmaceuticalsStrongly Bought Strongly Sold since October 1.

Here are the BidAskScore of other related companies in the Pharmaceuticals sector:

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-105, AR-101, AR-401, AR-201, and AR-501. The company was founded by Eric J. Patzer and Vu L. Truong in 2003 and is headquartered in San Jose, CA.

Aridis Pharmaceuticals, Inc.

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.